BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific
antibodies have been detected in human milk up to 6 weeks post–coronavirus disease 2019 …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are
being administered around the world; however, lactating women were excluded from SARS …

Background The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
pandemic has infected over 127 million people worldwide, with almost 2.8 million deaths at …

Objective Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of
individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity …

SARS-CoV-2-specific antibodies are secreted into human milk of infected or vaccinated
lactating women and might provide protection to the breastfed infant against COVID-19 …

Background Human milk contains antibodies against Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) following Coronavirus Disease 2019 (COVID-19). These …

METHODS We conducted a prospective cohort single-institution study from February 2 to
April 4, 2021. Women who reported to be breastfeeding at the time of their coronavirus …

Little is known about the persistence of human milk anti-SARS-CoV-2 antibodies after 2 nd
and 3 rd vaccine doses and infection following 3 rd dose. In this study, human milk, saliva …

Background: CDC guidelines have recommended coronavirus disease-19 (COVID-19)
vaccination for all people 5 years and older, including people who are breastfeeding. Breast …

Objective Assess presence, durability, and neutralization capacity of SARS-CoV-2-specific
antibodies in breastfeeding infants' stool, mother's plasma and milk following maternal …